Seth M. Steinberg

Active 1986–2025

Also published as
SETH M. STEINBERG
376
Papers
75,365
Citations
151
h-index
369
i10-index

Citations

Citations per year for Seth M. Steinberg1964: 1 citations1971: 1 citations1984: 1 citations1987: 1 citations1988: 14 citations1989: 16 citations1990: 40 citations1991: 61 citations1992: 57 citations1993: 57 citations1994: 83 citations1995: 125 citations1996: 136 citations1997: 162 citations1998: 181 citations1999: 203 citations2000: 228 citations2001: 258 citations2002: 310 citations2003: 362 citations2004: 501 citations2005: 552 citations2006: 518 citations2007: 571 citations2008: 544 citations2009: 539 citations2010: 565 citations2011: 560 citations2012: 596 citations2013: 568 citations2014: 503 citations2015: 578 citations2016: 612 citations2017: 701 citations2018: 662 citations2019: 1,863 citations2020: 1,989 citations2021: 2,123 citations2022: 1,660 citations2023: 1,214 citations2024: 1,873 citations2025: 889 citations2026: 12 citations1965–1970: no citations, so these years are not shown1972–1983: no citations, so these years are not shown1985–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 10,022 citing papers, 35.2% of this breakdownChina: 2,387 citing papers, 8.4% of this breakdownUnited Kingdom: 1,642 citing papers, 5.8% of this breakdownGermany: 1,540 citing papers, 5.4% of this breakdownItaly: 1,444 citing papers, 5.1% of this breakdownFrance: 1,169 citing papers, 4.1% of this breakdownCanada: 913 citing papers, 3.2% of this breakdownNetherlands: 820 citing papers, 2.9% of this breakdownJapan: 729 citing papers, 2.6% of this breakdownSpain: 699 citing papers, 2.4% of this breakdownAustralia: 667 citing papers, 2.3% of this breakdownSwitzerland: 621 citing papers, 2.2% of this breakdown
0%35.2%Other 20.4%

Fields

  • Medicine65.8%
  • Biochemistry, Genetics and Molecular Biology18.8%
  • Immunology and Microbiology9.1%
  • Chemistry2.2%
  • Computer Science1%
  • Engineering0.6%
  • Other2.5%

Topics

  • CAR-T cell therapy research6.5%
  • Cancer Immunotherapy and Biomarkers4.8%
  • Immunotherapy and Immune Responses4.5%
  • Immune Cell Function and Interaction3.1%
  • Lymphoma Diagnosis and Treatment2.4%
  • Virus-based gene therapy research1.6%
  • Other77.1%

Coauthors

All papers

Open in search
  1. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2014 cited by 2,938

  2. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

    Authors: , , , , , , , , , , , , , , - Clinical Cancer Research 2011 cited by 2,120

  3. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz and 10 more - The Lancet Oncology 2017 cited by 1,133

  4. Identification of essential genes for cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 904

  5. CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 416

  6. Selumetinib in Children with Inoperable Plexiform Neurofibromas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 698

  7. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2016 cited by 818

  8. Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 356

  9. Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 402

  10. Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nirali N. Shah - Blood 2021 cited by 189

  11. Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 203

  12. CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grégoire Altan‐Bonnet, David Stroncek, Terry J. Fry, Naomi Taylor, Nirali N. Shah - Blood 2022 cited by 175

  13. Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jessica D. Kindrick, Cody J. Peer, Jun S. Wei, Mirit I. Aladjem, William D. Figg, Seth M. Steinberg, Jane B. Trepel, Frank T. Zenke, Yves Pommier, Javed Khan, Craig J. Thomas - Cancer Cell 2021 cited by 177

  14. Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2022 cited by 140

  15. Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 221

  16. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

    Authors: , , , , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 458

  17. Use of proteomic patterns in serum to identify ovarian cancer

    Authors: , , , , , , , , , , - The Lancet 2002 cited by 3,256

  18. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 1998 cited by 1,531

  19. Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2017 cited by 499

  20. Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2023 cited by 71

  21. Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study

    Authors: , , , , , , , , , , , , , , , - The Lancet Oncology 2018 cited by 212

  22. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS)

    Authors: , , , , , , , , , , , , , , - Clinical Infectious Diseases 2015 cited by 227

  23. Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2019 cited by 181

  24. Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 101